RevMAb BioSciences

RevMAb Biosciences USA, Inc is a biotechnology company focused on the development of monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. Their team consists of pioneers in optimizing and transforming rabbit hybridoma technology for commercial application, and developing rabbit monoclonal antibodies for research, diagnostic and therapeutic use. With years of experience and strong expertise in antibody development, RevMAb’s team of scientists aim to revolutionize antibody generation and develop high quality products in order to reveal true science.